(Press-News.org) UCLA-led team finds a stem-cell derived mechanism that could lead to regenerative therapies for heart damage
A UCLA-led team has identified an essential internal control mechanism that can promote the maturation of human stem cell-derived heart muscle cells, offering a deeper understanding of how heart muscle cells develop from their immature fetal stage to their mature adult form.
The findings, published in the peer-reviewed journal Circulation, could lead to new therapies for heart disease and cardiac damage.
The collaborative effort with Duke-NUS Medical School in Singapore and other institutions identified an RNA splicing regulator named RBFox1, which was considerably more prevalent in adult heart cells than in newborns, based on a preclinical model. The sharp rise in RBFox1 during the maturation of heart cells was also confirmed through analyses of existing single-cell data.
“This is the first piece of evidence suggesting that RNA splicing control plays a vital role in postnatal heart cell maturation,” said study lead Jijun Huang, who conducted this research during his postdoctoral training in anesthesiology at UCLA. “While RBFox1 alone may not be sufficient to push mature fetal heart muscle cells all the way to fully matured adult cells, our findings uncover a new RNA-based internal network that can substantially drive this maturation process beyond other available approaches.”
The transformation of heart muscle cells from birth until they reach full maturity involves significant shifts in their structure, functionality, and physiological properties. The mechanisms overseeing this comprehensive maturation have been poorly understood thus far.
Although the precise mechanics associating RBFox1-mediated RNA splicing with ensuing maturation procedures and characteristics still require further exploration, the study provides proof-of-concept that modulating RNA splicing can profoundly affect cardiomyocyte maturation. This newfound knowledge hints at future therapeutic applications, pending additional research to expand upon these initial findings.
“For the first time, we've shown that by merely altering RNA splicing, we can encourage the significant maturation of heart cells derived from human stem cells,” said senior author Yibin Wang, director of the Cardiovascular & Metabolic Disorders Program at Duke-NUS. “These findings present a potential molecular approach to enhance heart cell maturation, which could address a major challenge in the domains of cardiac regenerative therapy and disease modeling.”
The study was funded by an American Heart Association Postdoctoral Award (18POST33990469) the National Institutes of Health (R01 HL148714, R00 HL141626) and a Department of Defense Award (PR171540).
Study co-authors are Josh Lee, Christoph Rau, Dr. Arash Pezhouman, Tomohiro Yokota, Hiromi Miwa, Tsz Kin Kong, Shreya Udani, Chen Gao, Linsey Stiles, Dr. Orian Shirihai, Dr. Reza Ardehali, and Dino Di Carlo of UCLA and others from Baylor College of Medicine, Vanderbilt University School of Medicine, Meharry Medical College, Forcyte Biotechnologies, the University of Cincinnati, the University of North Carolina, and the Agency for Science, Technology and Research (A*STAR) in Singapore.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.122.061602
END
UCLA-led team finds a stem-cell derived mechanism that could lead to regenerative therapies for heart damage
2023-10-18
ELSE PRESS RELEASES FROM THIS DATE:
Lung cancer treatment research enters a new era
2023-10-18
Advances in lung cancer treatment highlight importance of tumour testing at diagnosis
Research presented at the ESMO Congress 2023 sets potential major changes in first-line treatment for patients with NSCLC with targetable tumour cell mutations
Lugano, Switzerland, 17 October 2023 – More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7). Better outcomes were achieved with combinations ...
Scientists discover links between Alzheimer’s disease and gut microbiota
2023-10-18
Researchers have discovered the link between the gut microbiota and Alzheimer’s disease.
For the first time, researchers have found that Alzheimer’s symptoms can be transferred to a healthy young organism via the gut microbiota, confirming its role in the disease.
The research was led by Professor Yvonne Nolan, APC Microbiome Ireland, a world leading SFI funded research centre based at University College Cork (UCC), and the Department of Anatomy and Neuroscience, UCC, with Professor Sandrine Thuret at King’s ...
Transforming fossil fuels: University of Oklahoma, Kansas State University successfully complete DOE project
2023-10-18
NORMAN, Okla. (Oct. 17, 2023) -- In collaboration, the University of Oklahoma has taken the lead in a Department of Energy project, with support from Kansas State University, to pioneer a new generation of reversible electrochemical cells. The cells have the potential to revolutionize energy storage by integrating seamlessly with fossil fuel assets.
The project’s objective was to conduct an extensive study aimed at developing an energy storage technology capable of efficiently converting carbon dioxide emissions captured from fossil fuel assets into valuable fuels, such as methane, says ...
Genetic risk scores not useful in predicting disease
2023-10-18
Polygenic risk scores, which estimate a person’s disease risk based on thousands or millions of common genetic variants, perform poorly in screening and prediction of common diseases such as heart disease, according to a new study led by UCL (University College London) researchers.
It has been claimed that polygenic risk scores will transform the prediction and prevention of common diseases. Companies have already been established that sell polygenic risk score testing services. Polygenic risk score testing is also one of the aims of the nationwide Our Future Health project*.
The new study, published in BMJ Medicine, looked at 926 polygenic risk scores for 310 diseases. ...
Marine mammal longevity study reveals remarkable advances in animal welfare
2023-10-18
A new study provides compelling evidence that animal care and management practices at zoos and aquariums have significantly improved over time. The study, led by Species360 and University of Southern Denmark Research Scientist Dr. Morgane Tidière in collaboration with 41 co-authors from academic, governmental, and zoological institutions around the world, is the first to examine life expectancy and lifespan equality together as a proxy of population welfare in marine mammal species.
The study also found that marine mammal species live longer ...
New specimen collection system enhances assisted reproductive technologies
2023-10-18
New Specimen Collection System Enhances Assisted Reproductive Technologies
Considered an experimental procedure during the late 1970s when it made headlines with each birth it produced, in vitro fertilization (IVF) has helped many couples overcome infertility issues for more than four decades. In several nations, IVF is responsible for up to 3% of the babies born.
The procedure, now a cornerstone of infertility treatments, has expanded to include other assisted reproductive technologies (ARTs). One of those ARTs, known as intracytoplasmic sperm injection (ICSI), involves using a microscopic needle to inject a single sperm into an egg.
Though ...
Ludwig Cancer Research launches leadership fellows program
2023-10-17
OCTOBER 17, 2023, NEW YORK – It is with great pleasure that Ludwig Cancer Research announces its launch of the Ludwig Leadership Fellows Program.
Conceived, funded and managed by the Ludwig Institute for Cancer Research, the Program aims to accelerate the careers of exceptional young scientists by helping them establish genuinely independent programs of research immediately after the completion of their graduate studies.
“Our hope is that the Leadership Fellows program will contribute to a pipeline of outstanding future leaders of cancer research,” said Chi Van Dang, scientific director of the Ludwig Institute. “We and many others have grown increasingly alarmed ...
Paul “Bear” Bryant Awards announce 2023 college football coaches watch list
2023-10-17
HOUSTON, October 17, 2023 – Twenty-six active college football coaches make up the American Heart Association’s 2023 Paul “Bear” Bryant Coach of the Year Award watch list, a list of current coaches in consideration for the annual top honor. The award is given each January to a college football coach for contributions that make the sport better for athletes and fans alike by demonstrating grit, integrity and a winning approach to coaching and life - both on and off the field.
The ...
Lung, kidney, and neuroendocrine tumor cancer studies led by Dana-Farber presented at ESMO Congress 2023
2023-10-17
BOSTON – Novel treatments, combination therapies, and personalized medicine headline several studies led by Dana-Farber Cancer Institute and presented for the first time at the European Society of Medical Oncology (ESMO) Congress 2023 in Madrid, Spain. The studies will be presented both in-person and online on October 20-24, 2023. A full list of Dana-Farber oral abstracts is available here.
A pivotal lung cancer study (LBA65) led by Pasi Jänne, MD, PhD, director of the Lowe Center for Thoracic Oncology, looking at the efficacy and safety of adagrasib with pembrolizumab in patients that have advanced non-small cell lung ...
Last chance: Register in advance for media credentials to cover American College of Surgeons Clinical Congress 2023
2023-10-17
CHICAGO (October 17, 2023): Members of the media can still apply to cover the American College of Surgeons (ACS) Clinical Congress 2023. One of the largest international meetings of surgeons in the world, Clinical Congress will feature many opportunities to report on groundbreaking surgical research, connect with surgeon experts, and learn more about the latest trends in surgery.
When: October 22-25, 2023
Where: Boston, Massachusetts. This year’s conference will once again be a hybrid event (held onsite and virtually).
Apply: Please read the ACS Criteria for Media Credentials before submitting your application for credentials. Apply ...